The CLEI Center for Keratoconus: Research & Clinical Trials
The CLEI Center for Keratoconus is at the forefront of research and innovation in keratoconus treatment. We participate in a number of research studies and clinical trials designed deliver the most advanced care to patients with keratoconus.
The CLEI Center for Keratoconus is directed by Dr. Peter S. Hersh, the medical monitor and lead author of the study leading to FDA approval of corneal cross linking for keratoconus. Dr. Hersh, along with Dr. Steven A. Greenstein, and Dr. John D. Gelles have published extensively on management of keratoconus in the most prominent ophthalmology journals, such as Ophthalmology, Journal of Cataract and Refractive Surgery, Journal of Refractive Surgery, Cornea, and Eye and Contact Lens.
Below you will find our actively recruiting clinical trials:
Corneal Tissue Inlay for Keratoconus: This study will evaluate the outcomes of placing preserved corneal tissue within the keratoconic cornea in order to enhance thickness, stability, and optical conformation.
Wavefront Guided Scleral Lenses for Keratoconus and Irregular Astigmatism: This study will evaluate the outcomes of wavefront guided scleral lenses in order to improve vision and reduce higher order aberrations in keratoconus and irregular astigmatism.
If you are interested in participating in a clinical trial please schedule a consultation to evaluate your candidacy.
